The fucosylation index of α-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma

Cancer

Volumn 83, Issue 10, 1998, Pages 2076-2082

  Aoyagi, Yutaka ^a   Isokawa, Osamu ^a   Suda, Takeshi ^a   Watanabe, Masashi ^a   Suzuki, Yasufumi ^a   Asakura, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

fetoprotein; Fucosylation index; Hepatocellular carcinoma; Prognostic factor; Survival rate

Indexed keywords

AGGLUTININ; ALCOHOL; ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; ENZYME IMMUNOASSAY; FEMALE; FUCOSYLATION; HUMAN; IMMUNOELECTROPHORESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ALPHA-FETOPROTEINS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; FUCOSYLTRANSFERASES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; SURVIVAL RATE;

EID: 0032533277     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981115)83:10<2076::AID-CNCR5>3.0.CO;2-L     Document Type: Article

References (43)

1. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 1984;62:163-83.
2. Okuda K and the Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Cancer 1980;45:2663-9.
3. Abelev GI. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res 1968;28:1344-50.
4. O'Conor GI, Tatarinov YS, Abelev GI, Uriel J. A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer 1970;25:1091-8.
5. Nagasue N, Inokuchi K, Kobayashi M, Saku M. Serum alpha-fetoprotein levels after hepatic artery ligation and postoperative chemotherapy: correlation with clinical status in patients with hepatocellular carcinoma. Cancer 1977;40:615-8.
6. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels: analysis of 606 patients. Cancer 1989;64:1700-7.
7. Johnson PJ, Williams R. Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection. J Natl Cancer Inst 1980;64:1329-32.
8. Yamashita Y, Takahashi M, Koga Y, Saito R, Nanakawa S, Hatanaka Y, et al. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 1991;6:385-91.
9. Izumi R, Shimizu K, Kiriyama M, Hashimoto T, Urade M, Yagi M, et al. Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival. J Surg Oncol 1992;49:151-5.
10. Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer 1996;78:2094-100.
11. Yamashita F, Tanaka M, Satomura S, Tanikawa K. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology 1996;111:996-1001.
12. Yamashita F, Tanaka M, Satomura S, Tanikawa K. Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization. Eur J Gastroenterol Hepatol 1995;7:627-33.
13. Aoyagi Y, Suzuki Y, Isemura M, Soga K, Ozaki T, Ichida T, et al. Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma. Gann 1984;75:809-15.
14. Aoyagi Y, Isemura M, Suzuki Y, Sekine C, Soga K, Ozaki T, et al. Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma. Lancet 1985;ii:1353-4.
15. Aoyagi Y, Suzuki Y, Isemura M, Nomoto M, Sekine C, Igarashi K, et al. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988;61:769-74.
16. Aoyagi Y. Carbohydrate-based measurement on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma. Glycoconjugate J 1995;12:194-9.
17. Breborowicz J, Mackiewicz A, Breborowicz D. Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol 1981;14:15-20.
18. Taketa K, Hirai H. Lectin affinity electrophoresis of alpha-fetoprotein in cancer diagnosis. Electrophoresis 1989; 10:562-7.
19. Taketa K, Sekiya C, Namiki M, Akamatsu K, Ohta Y, Endo Y, et al. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 1990;99:508-18.
20. van Staden L, Bukofzer S, Kew MC, Savage N. Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised. J Gastroenterol Hepatol 1992;7:260-5.
21. Tu Z, Yin Z, Wu M. Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin. Chin Med Sci J 1992;7:191-6.
22. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. New Engl J Med 1993;328:1802-6.
23. Kuromatsu R, Tanaka M, Tanikawa K. Serum alpha-fetoprotein and Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma. Liver 1993;13:177-82.
24. Ajdukiewicz AB, Kelleher PC, Krawitt EL, Walters CJ, Mason PB, Koff RS, et al. Alpha-fetoprotein glycosylation is abnormal in some hepatocellular carcinoma, including white patients with a normal alpha-fetoprotein concentration. Cancer Lett 1993;74:43-50.
25. Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, et al. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 1993;53:5419-23.
26. Shiraki K, Takase K, Tameda Y, Hamada M, Kosaka Y, Nakano T. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Hepatology 1995;22:802-7.
27. Wang SS, Lu RH, Lee FY, Chao Y, Huang YS, Chen CC, et al. Utility of lentil lectin affinity of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. J Hepatol 1996;25: 166-71.
28. Aoyagi Y, Isemura M, Yosizawa Z, Suzuki Y, Sekine C, Ono T, et al. Fucosylation of serum alpha-fetoprotein with primary hepatocellular carcinoma. Biochim Biophys Acta 1985;830: 217-23.
29. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. Br J Cancer 1993;67:486-92.
30. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro M, Yokota T, et al. The usefulness of the simultaneous determination of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 1991;67:2390-4.
31. International Union Against Cancer. Hermanek P, Sobin LH, editors. TNM classification of malignant tumors. 4th edition. Berlin: Spring-Verlag, 1987.
32. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 3rd edition. Tokyo: Kinbara Shuppan Co. Ltd., 1992.
33. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
34. Ebara M, Ohto M, Sugiura N, Kita K, Yoshikawa M, Okuda K, et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: study of 95 patients. J Gastroenterol Hepatol 1990;5:616-26.
35. Ichida T, Kato M, Hayakawa A, Ito S, Mori S, Sato T, et al. Therapeutic effect of a CDDP-epirubicin-Lipidol emulsion on advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33(Suppl):S74-8.
36. Liver Cancer Study Group of Japan. The criteria for the evaluation of the therapeutic effect to the liver [in Japanese]. Acta Hepatol Jpn 1994;35:193-205.
37. Uozumi N, Yanagidani S, Miyoshi E, Ihara Y, Sakuma T, Gao CX, et al. Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alphal-6fucosyltransferase. J Biol Chem 1996;271:27810-7.
38. Uozumi N, Teshima T, Yamamoto T, Nishikawa A, Gao YE, Miyoshi E, et al. A fluorescent assay method for GDP-L-Fuc: N-acetyl-beta-D-glucosaminide alpha 1-6fucosyltransferase activity, involving high performance liquid chromatography. J Biochem (Tokyo) 1996;120:385-92.
39. Sekine C, Aoyagi Y, Suzuki Y, Ichida F. The reactivity of alpha-1-antitrypsin with Lens culinaris agglutinin and its usefulness in the diagnosis of neoplastic diseases of the liver. Br J Cancer 1987;56:371-5.
40. Aoyagi Y, Isemura M, Suzuki Y, Sekine C, Soga K, Ozaki K, et al. Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells. Lancet 1986;i:210.
41. Taketa K, Ichikawa E, Taga H, Hirai H. Antibody-affinity blotting: a sensitive technique for the detection of alphafetoprotein separated by lectin affinity electrophoresis in agarose gels. Electrophoresis 1985;6:492-7.
42. Moriwaki H, Yasuda I, Shiratori Y, Uematsu T, Okuno M, Muto Y. Deletion of serum lectin-reactive a-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma. Clin Cancer Res 1997;3:727-31.
43. Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan: report 12 [in Japanese]. Acta Hepatol Jpn 1997;38:317-30.